But star performers don’t automatically create high-performing teams—and AI can make things worse. Duke dean and professor ...

The reform shifts routine compliance to para-professionals, creating fee pressure and client shifts. Professionals must move toward advisory roles to remain ...

What makes Codex useful for building websites is that it can install software packages, run a local preview server, track ...

Whether Albany will keep providing health coverage for these people is rapidly becoming a main sticking point in this year’s ...

Some things are just fundamentally part of American culture. Baseball. Apple pie. Catchy ad campaigns. And small-block Chevrolets. For only the sixth time since the small-block arrived inside the ...

PEMISCOT COUNTY, Mo. (KAIT) - The U.S. Geological Survey recorded a minor earthquake early Wednesday morning near the Arkansas-Missouri border. The magnitude 2.3 tremor, which occurred at 4:13 a.m.

The Audi Q3 sits on the Volkswagen Group's MQB Evo platform, which it shares with the Audi A3, the VW Golf, and the VW Tiguan. The new model is larger than its predecessor, being 1.8 inches longer and ...

Following two weekends of bad weather and a partial government shutdown, TSA agents are working without pay and the lines to get through airport security are getting longer. Hartsfield-Jackson Atlanta ...

Small businesses are combining n8n and Blotato to replace manual social media scheduling with simple, repeatable automation workflows. As small businesses face increasing pressure to stay visible ...

What Is Hernexeos, and Why Does It Matter? Hernexeos (zongertinib) is a prescription medicine known as a kinase inhibitor that is used for treating adults with advanced non-small-cell lung cancer ...

Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer Ingelheim's zongertinib as a first-line treatment for a rare form of non-small cell lung cancer, making it the ...

A Boehringer Ingelheim drug now has FDA approval as an earlier treatment for lung cancers expressing a certain genetic signature, a regulatory decision handed out under the agency’s new pilot program ...